The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Popular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

If you came here wondering what prediabetes means, we’ll answer it simply: Prediabetes, often considered the step before ...